PetIQ, Inc. (PETQ) Financials
PETQ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 868.2 million | 645.2 million |
| 2023-09-30 | 857.1 million | 617.9 million |
| 2023-06-30 | 883.5 million | 647.9 million |
| 2023-03-31 | 867.7 million | 644.6 million |
PETQ Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -5.8 million | 1.4 million |
| 2023-09-30 | 48.2 million | 2.9 million |
| 2023-06-30 | 55.5 million | 2.7 million |
| 2023-03-31 | -45.2 million | 2.5 million |
PETQ Net Income
No data available :(
PETQ Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 116.4 million | - | 21.9 million |
| 2023-09-30 | 124.6 million | - | 16.3 million |
| 2023-06-30 | 78.4 million | 440.6 million | 17.0 million |
| 2023-03-31 | 25.4 million | 441.9 million | 18.1 million |
PETQ Shares Outstanding
PETQ Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2.9 million | - | 42.7 million | - |
| 2023-09-30 | 2.1 million | - | 55.0 million | - |
| 2023-06-30 | 2.2 million | - | 55.2 million | - |
| 2023-03-31 | 1.9 million | - | 52.0 million | - |
PETQ Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 219.9 million | 175.9 million |
| 2023-09-30 | 277.0 million | 204.4 million |
| 2023-06-30 | 314.5 million | 240.7 million |
| 2023-03-31 | 290.5 million | 228.2 million |
PETQ
Price: $17.65
52 week price:
Earnings Per Share: 0.07 USD
P/E Ratio: 39.34
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 192400
Ebitda: 2.8 millionMarket Capitalization: 522.4 million